Looking for Mounjaro in Česká Republika? Here's the UK picture

Mounjaro (tirzepatide) is a prescription-only medicine in the UK; it cannot legally be supplied without a full clinical assessment by a GPhC-registered prescriber.
Licensing conditions, available doses and prescribing criteria vary between EU member states and the UK, which has its own MHRA approval framework since leaving the EEA.
The UK-licensed dose range runs from a 2.5 mg starting pen through to 15 mg; the treatment schedule is set by the prescriber, not chosen by the patient.
Counterfeit tirzepatide pens are actively traded online across Europe; the MHRA has carried out large enforcement actions, including seizures of around 20 million doses with an estimated street value of ~£45 million.

If you've been searching for Mounjaro in the Czech Republic, the short answer is that tirzepatide's licensing, prescribing rules and availability differ country by country across Europe. In the UK, Mounjaro is a prescription-only medicine licensed for weight management in adults, dispensed only after a clinical assessment by a qualified prescriber. Moving between countries — or researching options across borders — can make the regulatory picture genuinely confusing, and that confusion is worth untangling carefully before you do anything else. This page explains how the UK framework actually works, so you can make sense of what you're reading online and understand what safe access looks like here.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Tirzepatide in the UK: what the rules mean for you in practice

The myth worth clearing up first: European approvals don't cross borders automatically

A very common assumption is that if a medicine is approved somewhere in Europe, it can be freely brought into or ordered to the UK. That's not how it works. Since the UK left the EEA, the MHRA operates as a completely independent medicines regulator. A marketing authorisation granted by the EMA (which covers EU member states including the Czech Republic) is a separate licence from the MHRA's UK approval. The two processes often reach similar conclusions, but they run on different timetables and carry different legal weight in different jurisdictions.

In practice, this means a pack of Mounjaro dispensed by a Czech pharmacy is authorised for use under Czech law, not UK law. Bringing it in for personal use sits in a legal grey area at best; selling or supplying it here is straightforwardly unlawful. People who come across listings for tirzepatide shipped from overseas often assume the EU approval makes it legitimate in the UK, and if you're unsure what names this medicine travels under, our page covering tirzepatide and its various aliases is worth a look. That's the misconception, and once you understand it, the safer path becomes obvious.

The MHRA's own public guidance on GLP-1 medicines makes this point plainly, and it's worth reading if you're uncertain about what you've seen advertised online.

What genuine UK access to Mounjaro actually looks like

In the UK, tirzepatide is licensed under the Mounjaro brand by Eli Lilly for two indications: weight management in adults with a BMI of 30 or above (or 27 or above with at least one weight-related health condition), and type 2 diabetes management. Both routes require a prescription from a registered prescriber who has reviewed your medical history.

For weight management specifically, NICE recommended tirzepatide in December 2024 (technology appraisal TA1026) for adults meeting defined BMI and comorbidity thresholds on the NHS. Private access has a broader footprint: a prescriber can lawfully prescribe Mounjaro to an eligible adult through a GPhC-registered online pharmacy, typically without the waiting times that NHS pathways currently involve.

The six licensed dose strengths (2.5, 5, 7.5, 10, 12.5 and 15 mg) are each supplied in a pre-filled KwikPen delivering four weekly injections. Treatment always begins at 2.5 mg. That starting dose is there to let your body adjust; the prescriber decides when and whether to move upward, based on your response and tolerance. If you'd like to understand how tirzepatide works as a medicine before going further, that's a reasonable place to start.

Why buying from unverified overseas sources carries real risk

The temptation to order from a cheaper or apparently more accessible overseas source is understandable, particularly if NHS waiting times feel remote or private UK prices feel steep. Context on what UK private treatment costs is worth reading, and our Mounjaro pricing page covers the range honestly, including what happened to list prices after Eli Lilly's September 2025 adjustment.

The safety concern is not abstract. The MHRA raided an illicit manufacturing site in Northampton in October 2025 that was producing counterfeit tirzepatide pens for distribution, and enforcement operations through 2025 recovered approximately 20 million doses of illegally traded weight-loss medicines. Counterfeit pens have contained insulin in previous incidents, an error that can be life-threatening. Some suppliers also advertise formulations such as sublingual tirzepatide, which our dedicated page explains in full, and it is worth understanding exactly what those products are before considering them. The fact that a listing is written in English, or carries a brand logo, or arrives in convincing packaging is not evidence that the product is genuine.

The safe check is simple: look up any pharmacy you're considering on the GPhC public register. If it isn't listed there, it isn't a UK-regulated pharmacy, and there is no regulatory framework protecting what it sends you. If you want practical guidance on telling legitimate options apart from the rest, our page on finding reputable Mounjaro in the UK covers exactly that. You can also report suspect sellers directly through the MHRA's Yellow Card scheme.

How nume's UK clinical pathway works

At nume, every consultation is read by a GPhC-registered Independent Prescriber, a real clinician, the same day you submit. There is no algorithm making approval decisions. Identity is verified by photo ID; weight is confirmed on a live video call. Medicines travel through the licensed UK supply chain from authorised distributors, and if you'd like more background on how to identify reputable Mounjaro suppliers in the UK, that page sets out what to look for.

Orders placed before 12pm on weekdays are dispatched the same day once clinically approved, arriving by DPD the next working day in plain, unbranded packaging. The price covers the consultation, the prescription, the medicine and delivery; there are no separate fees to find later. If you want to understand who reviews your application, our clinical team page has those details.

If you're weighing whether this is the right route for your situation, the weight-loss treatment overview covers what's licensed in the UK and how the options compare. Specific questions can go to our FAQs or our support team directly. And if you're ready to see whether you meet the clinical criteria, you can check your eligibility at no cost.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions